The Cancer Biotherapy And Radiopharmaceuticals is reputed journal publishes research related to Biochemistry, Genetics and Molecular Biology; Medicine; Pharmacology, Toxicology and Pharmaceutics. The ISSN of the journal is 15578852.
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | Cancer Biotherapy and Radiopharmaceuticals |
|---|---|
| Publisher | Mary Ann Liebert Inc. |
| Publication Country | 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801 |
| ISSN | 15578852 |
| Publication Area | Oncology | Medicine, Research & Experimental | Pharmacology & Pharmacy | Radiology, Nuclear Medicine & Medical Imaging |
| Publication Language | English |
| Review Process | |
| Scopus Indexed | Yes |
The Impact Factor of Cancer Biotherapy And Radiopharmaceuticals in 2026 is 2.4.
The Cancer Biotherapy And Radiopharmaceuticals is ranked in Q2.
The Cancer Biotherapy And Radiopharmaceuticals is indexed in: Scopus, Web of Science, PubMed, Embase, UGC CARE Group 2.